Thermo Scientific Introduces Two Size Exclusion HPLC Chromatography Columns
January 18, 2013
Thermo Fisher Scientific is pleased to introduce new Thermo Scientific Acclaim SEC-300 and SEC-1000 size exclusion HPLC columns designed for the high-resolution separation of water soluble polymers and oligomers. The columns are optimized for determining molecular weight distribution and characterization of water soluble polymers used in a wide range of products found in pharmaceuticals, medicines, [...]
January 18, 2013
Block Engineering, the leader in Quantum Cascade Laser (QCL) spectroscopy, announced today that it has signed a Collaborative Agreement with Pfizer, Inc. to develop a QCL-based system for real-time, noncontact Cleaning Verification of vessels during pharmaceutical manufacturing. The technology is based on Block's commercially available LaserScan ™ Analyzer, which will be tailored to address the [...]
Statement by Life Technologies’ Board of Directors
January 18, 2013
CARLSBAD, Calif., -- The board of directors of Life Technologies Corporation has retained Deutsche Bank Securities Inc. and Moelis & Company LLC to assist in its annual strategic review. The board of directors has not decided on any specific course of action. About Life Technologies Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company [...]
Thermo Scientific Syncronis HPLC Columns
January 18, 2013
SUNNYVALE, CA — Thermo Fisher Scientific is pleased to announce that Thermo Scientific™ Syncronis™ HPLC columns are now available with 3 ?m. particle size. This new particle size complements the existing 1.7 and 5 µm particle sizes. “This builds on the heritage of the Syncronis family of LC columns, which offer consistent, reproducible separations with [...]
New platform to measure genetic variations in livestock
January 18, 2013
State-of-the-art testing to measure genetic variations in livestock, and to identify inherited diseases within herds, will soon be available in Australia at The University of Queensland's Animal Genetics Laboratory (AGL). The AGL in UQ's School of Veterinary Science has this week signed a service agreement with the Nebraska-based agri-genomics company, GeneSeek Inc, a Neogen Company, [...]
Integrating analyzers with ease: New developments extend the benefits of Malvern Link II
January 17, 2013
Malvern, UK: Malvern Instruments has added new functionality to its Malvern Link II product, the powerful software package that enables the integration of multiple analyzers within an automated control platform. The latest developments extend the benefits of Malvern Link II to the company’s Mastersizer and Zetasizer analyzer ranges, streamlining their use for applications in process [...]
January 17, 2013
IMGM Laboratories, a genomic service provider based in Martinsried/Munich, has recently upgraded its next generation sequencing-based Metagenomics services. Metagenomics - the study of genomic content in a complex mixture of microorganisms – is a currently very active field. With a fleet of Roche 454 instruments and specialized know-how, IMGM generates high information content data sets [...]
Agilent Technologies Authorizes New Share Repurchase Program and Increases Quarterly Dividend
January 17, 2013
Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has authorized the repurchase of up to $500 million of the company's common stock during fiscal 2013. The new repurchase authorization replaces Agilent's existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs. The [...]
Pall Corporation Board of Directors Declares Dividend and Increases Share Repurchase Authorization
January 17, 2013
PORT WASHINGTON, N.Y., - Pall Corporation (NYSE:PLL) today announced that its board of directors declared a quarterly dividend of 25 cents per share. The dividend is payable on February 22, 2013 to shareholders of record on the close of business on February 8, 2013. The board also increased the company's authorization to repurchase shares of [...]
Cellular Dynamics Announces the Production of Human iPSC Lines Under cGMP Conditions
January 17, 2013
MADISON, WIS., –Cellular Dynamics International, Inc. (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells for drug discovery and safety, today announced that it is producing human iPSC master cell banks from five individual donors under current Good Manufacturing Practices (cGMPs). Manufacturing human iPSCs and ultimately human cells [...]
